-
Sinopharm and Gilead announce cooperation
It is understood that both parties will make full use of their respective advantages in pharmaceutical innovation, market development, channel and ret...
2020-09-14 10:07 -
China's export volume of raw materials increased by 16.68%
Among the reasons for the increase in sales and sales of API-related businesses, it was found that many pharmaceutical companies mentioned the impact ...
2020-09-11 16:35 -
Sinovac reports preliminary Phase I / II results of COVID-19 vaccine in elderly
Sinovac Biotech Ltd. a leading provider of biopharmaceutical products in China, announced that the inactivated COVID-19 vaccine candidate developed by...
2020-09-11 14:57 -
Sinopharm inactivated COVID-19 vaccines could be available by the end of 2020
Two new inactivated COVID-19 vaccines developed by Sinopharm(CNPGC) were also unveiled for the first time at the 2020 China International Fair for Tra...
2020-09-07 18:02 -
Results from Russian trials find vaccine candidates led to no serious adverse
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that...
2020-09-07 11:14 -
In 2027, the global API market will exceed US$280 billion
In 2019, the global API market size was approximately US$168.87 billion, and it is expected to exceed US$285.5 billion by 2027. From 2020 to 2027, the...
2020-09-04 14:49 -
Highlight: 3 major trends in the special raw material medicine industry report
The profitability of specialty API companies continued to improve. The average revenue growth rate of the 9 companies reached 24.42%, far exceeding th...
2020-09-03 14:12 -
All indicators of Chinese medicine improved in the first half of the year
According to the data from the China Pharmaceutical Industry Information Center, the main business income of the national pharmaceutical industry (8 s...
2020-09-02 14:30 -
In the 'no resistance' era, citral is promising!
The advent of antibiotics not only saved tens of thousands of lives, but also an important guarantee for the sustainable development of mankind.
2020-09-01 16:28 -
Liability risks emerge as an obstacle in Europe's COVID-19 vaccine negotiations
With all eyes on the hunt for COVID-19 vaccines, Europe’s supply negotiations with drugmakers have hit snags over potential liability for side effect...
2020-09-01 15:29
Hot News
- Wanhua Signs 70K HDI Acquisiti... Apr 16, 2025
- Kuwait Petroleum subsidiary ac... Apr 27, 2025
- Global Chemical Supply Chain C... Apr 30, 2025
- BASF Divests Two Joint Venture... Apr 23, 2025
- 3 Reasons INVISTA Reversed its... Apr 22, 2025
Related Products